JNJ-54175446
N/A
Report date: 2024/12/06 20:00:46
NME
Base Information
Drug NameJNJ-54175446
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory +[5]
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesJohnson & Johnson Innovative Medicine
China Registration ClassN/A
Develop Information
Active CompaniesJanssen Pharmaceuticals Inc
Inactive CompaniesJanssen-Cilag International NvJanssen Research & Development Llc
Active Indications
Inactive IndicationsN/A
Other Information
ATC CodeN/A
Related LinksN/A